Sign Up to like & get
recommendations!
1
Published in 2022 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.25928
Abstract: A major barrier to therapeutic development in neonates is a lack of standardized drug response measures that can be used as clinical trial endpoints. The ability to quantify treatment response in a way that aligns…
read more here.
Keywords:
corticosteroid response;
bronchopulmonary dysplasia;
response;
predicts bronchopulmonary ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Nature Reviews Clinical Oncology"
DOI: 10.1038/s41571-019-0189-1
Abstract: than those without a pCR (63.8% versus 33.5%; P < 0.001). Applying an exploratory cut-off value of a 40% reduction in SULmax yielded an 86% level of sensitivity and a specificity of 55%. Most notably,…
read more here.
Keywords:
pet response;
response;
early pet;
reduction sulmax ... See more keywords